Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity.

Payne JN, Badwaik VD, Waghwani HK, Moolani HV, Tockstein S, Thompson DH, Dakshinamurthy R.

Int J Nanomedicine. 2018 Mar 28;13:1917-1926. doi: 10.2147/IJN.S143506. eCollection 2018.

2.

Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity.

Payne JN, Waghwani HK, Connor MG, Hamilton W, Tockstein S, Moolani H, Chavda F, Badwaik V, Lawrenz MB, Dakshinamurthy R.

Front Microbiol. 2016 May 2;7:607. doi: 10.3389/fmicb.2016.00607. eCollection 2016.

3.

Inequalities in access to knee joint replacements for people in need.

Yong PF, Milner PC, Payne JN, Lewis PA, Jennison C.

Ann Rheum Dis. 2004 Nov;63(11):1483-9.

4.

Inequalities in accessing hip joint replacement for people in need.

Milner PC, Payne JN, Stanfield RC, Lewis PA, Jennison C, Saul C.

Eur J Public Health. 2004 Mar;14(1):58-62.

PMID:
15080393
5.

The SF36 as an outcome measure of services for end stage renal failure.

Wight JP, Edwards L, Brazier J, Walters S, Payne JN, Brown CB.

Qual Health Care. 1998 Dec;7(4):209-21.

6.

Lipid-lowering for prevention of coronary heart disease: what policy now?

Ul Haq I, Ramsay LE, Pickin DM, Yeo WW, Jackson PR, Payne JN.

Clin Sci (Lond). 1996 Oct;91(4):399-413. Erratum in: Clin Sci (Colch) 1996 Dec;91(6):773-4.

PMID:
8983865
7.

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.

Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN.

Lancet. 1996 Aug 10;348(9024):387-8. No abstract available. Erratum in: Lancet. 1996 Nov 2;348(9036):1251.

PMID:
8709740
8.

The pursuit of research publications.

Payne JN, Block M, Milner PC.

J Public Health Med. 1995 Sep;17(3):251-3. No abstract available.

PMID:
8527175
10.

Local confidential inquiry into avoidable factors in deaths from stroke and hypertensive disease.

Payne JN, Milner PC, Saul C, Bowns IR, Hannay DR, Ramsay LE.

BMJ. 1993 Oct 23;307(6911):1027-30.

12.

Meningococcal meningitis and meningococcal septicaemia: both are notifiable diseases.

Baxter AP, Payne JN.

Lancet. 1993 Feb 6;341(8841):378. No abstract available.

PMID:
8094149
15.
17.

Cerebellar afferents in early postnatal rats: a retrograde fluorescence study.

Payne JN, Bower AJ.

Brain Res. 1988 Apr 1;467(2):313-8.

PMID:
3378180
18.

Accurate counting of neurons in frozen sections: some necessary precautions.

Cooper JD, Payne JN, Horobin RW.

J Anat. 1988 Apr;157:13-21.

19.

Cerebellar afferents from the lateral reticular nucleus in the rat.

Payne JN.

Neuroscience. 1987 Oct;23(1):211-21.

PMID:
3683861
20.

A temperature controlled chamber to allow observation and measurement of uptake of fluorochromes into live cells.

Payne JN, Cooper JD, MacKeown ST, Horobin RW.

J Microsc. 1987 Sep;147(Pt 3):329-35.

PMID:
3430579
21.
22.

Histochemical implications of the chemical and biological properties of SITS and some related compounds.

Horobin RW, Payne JN, Jakobsen P.

J Microsc. 1987 Apr;146(Pt 1):87-96.

PMID:
2439692
23.
27.

Quantitative analysis of the topographical organization of olivocerebellar projections in the rat.

Payne JN, Wharton SM, Lawes IN.

Neuroscience. 1985 Jun;15(2):403-15.

PMID:
4022331
29.

SITS: an unavailable reagent?

Proctor GB, Horobin RW, Payne JN, Lawes IN.

Histochem J. 1984 May;16(5):579-82. No abstract available.

PMID:
6735743
30.

The motor effects of commercial samples of SITS.

Lawes IN, Payne JN, Proctor GB, Horobin RW.

J Neurosci Methods. 1984 Feb;10(2):145-7. No abstract available.

PMID:
6748735
31.

Variation between different samples of SITS with respect to axonal transport and toxicity.

Payne JN, Lawes IN, Proctor GB, Horobin RW.

Neurosci Lett. 1983 Dec 11;42(3):229-34.

PMID:
6198609
32.
35.

Stereotaxic operations via the foramen magnum in the rat.

Payne JN.

J Neurosci Methods. 1982 Jul;6(1-2):145-56. No abstract available.

PMID:
6750256
36.

The use of hyaluronidase in caudal block anesthesia.

PAYNE JN, RUPP NH.

Anesthesiology. 1951 Mar;12(2):164-72. No abstract available.

PMID:
14819682

Supplemental Content

Loading ...
Support Center